| Trial registration number
|
IRCT20200421047153N1 |
Full text link
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/47337
|
First author
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Farshad Hashemian
|
Contact
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
t.tarjoman@iautmu.ac.ir
|
Registration date
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2020-12-19
|
Recruitment status
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Prevention
|
Inclusion criteria
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18-65 years old
No symptoms of corona and no positive corona test
The desire to participate in the study
No symptoms of disease at the time of admission
No positive test
|
Exclusion criteria
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
History of allergy to hydroxychloroquine
Contraindications for drug use include previous history of retinopathy or G6PD, LONG QT SYNDROME, porphyry
Positive HIV patients
Patients with autoimmune diseases (lupus-rheumatoid arthritis)
BMI >40
Diabetic
CKD
Using medications with contraindication to use hydroxychloroquine
|
Number of arms
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Islamic Azad University
|
Inclusion age min
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
65
|
Countries
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Healthy volunteers
|
Severity scale
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
N/A
|
Total sample size
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
1000
|
primary outcome
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
incidence of mild type covid-19 (fever - cough - dyspnea- positive PCRtest)-CDC
incidence of severe type (dyspnea - chest pain or pressure - decreased level of consciousness - bruising of the lips and face and positive PCR test) based on CDC definition
|
Notes
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : Dec. 20, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|